Novartis cuts 114 more jobs at New Jersey HQ as restructuring rolls on

Summary: Novartis is a big medicine company. They are cutting 114 jobs at their main U.S. office in New Jersey. They are changing their sales team that works with rare diseases. The company says they need to change to help patients better and get ready for new medicines. Novartis has been letting people go since 2022. They are facing a big challenge in 2026 when patents for some of their biggest medicines expire. While they are cutting sales and office jobs, they are actually hiring more people to make the medicines in the U.S.

For more details, see rssapp-fiercepharma-com at fiercepharma.com/pharma/novartis-cuts-114-more-jobs-new-jersey-hq-restructuring-reverberates (opens in new tab)